Robert W. Schrepfer, SVP - New Business Development & Spec Sales at ANI PHARMACEUTICALS INC (ANIP), sold 46,104 shares at $60.33 ($2.8M) on 2018-03-01, disclosed to the SEC on 2018-03-05.
Open-market sale of $2.8M ANIP by SVP - New Business Development & Spec Sales. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.33 | 5,498 | $332K | 11.7% |
| 2 | $60.33 | 5,498 | $332K | 11.7% |
| 3 | $61.64 | 10,800 | $666K | 23.4% |
| 4 | $62.25 | 11,954 | $744K | 26.2% |
| 5 | $62.25 | 11,954 | $744K | 26.2% |
| 6 | $63.07 | 400 |
| $25K |
| 0.9% |
| Total | $61.66 avg | 46,104 | $2.8M | 100% |
| Filing → |
| ANIP | SELL | 2016-08-09 | $838K | — | Filing → |